Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Kidney International

• Publication date

  1999-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.1999.00798.XPMID 10594783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group.

  1999cited by this paper
• Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.

  1998cited by this paper
• Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.

  1998cited by this paper
• No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis.

  1998cited by this paper
• Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.

  1997cited by this paper
• Decreased Hepatic Insulin-Like Growth Factor (IGF)-I and Increased IGF Binding Protein-1 and -2 Gene Expression in Experimental Uremia.

  1997cited by this paper
• Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor.

  1997cited by this paper
• Derangements of the somatotropic hormone axis in chronic renal failure.

  1997cited by this paper
• The serum growth hormone binding protein: pregnant with possibilities.

  1997cited by this paper
• Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group.

  1997cited by this paper
• Insulin-like growth factors (IGFs) and IGF binding proteins, serum acid-labile subunit and growth hormone binding protein in nephrotic children.

  1997cited by this paper
• Growth Hormone Treatment in Growth Retarded Children with End Stage Renal Failure: Effect on Free/Dissociable IGF-I Levels

  1997cited by this paper
• Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions

  1997cited by this paper
• A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin.

  1996cited by this paper
• Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure.

  1996cited by this paper
• Growth hormone, the insulin-like growth factor system, and the kidney.

  1996cited by this paper
• Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.

  1995cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• Free insulin-like growth factors in human obesity.

  1995cited by this paper
• Metabolic clearance of recombinant human growth hormone in health and chronic renal failure

  1995cited by this paper
• Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II.

  1995cited by this paper
• Serum proteolysis of IGFBP-3.

  1995cited by this paper
• The free form of insulin-like growth factor I increases in circulation during normal human pregnancy.

  1995cited by this paper
• Nutritional regulation of the insulin-like growth factors.

  1994cited by this paper
• Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.

  1994cited by this paper
• Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serum

  1994cited by this paper
• In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells.

  1994cited by this paper
• Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure.

  1994cited by this paper
• Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men.

  1994cited by this paper
• Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3.

  1993cited by this paper
• Proteases acting on IGFBPs: their occurrence and physiological significance.

  1993cited by this paper
• Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia

  1991cited by this paper
• A simple assay for proteolysis of IGFBP-3.

  1991cited by this paper
• Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy.

  1990cited by this paper
• Insulin-like growth factors and their binding proteins.

  1990cited by this paper
• A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.

  1988cited by this paper
• Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure.

  1987cited by this paper
• Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

  1986cited by this paper
• Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.

  1986cited by this paper
• Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique.

  1985cited by this paper
• Somatomedin inhibitor in uremia.

  1984cited by this paper
• Somatomedin in growth disorders and chronic renal insufficiency in children.

  1977cited by this paper
• Growth hormone in uremia. I. Plasma growth hormone, insulin and glucagon after oral and intravenous glucose in uremic subjects.

  1971cited by this paper

• Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly

  2025cites this paper
• The multiple functions of insulin-like growth factor 1 in kidney disease.

  2025cites this paper
• Circulating Muscle Markers for Sarcopenia in Peritoneal Dialysis

  2025cites this paper
• The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines.

  2024cites this paper
• Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin

  2024cites this paper
• Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial

  2023cites this paper
• Resistance Training Improved the Kidney Function of Type 2 Diabetic Patients with the Risk of Nephropathy: A Randomized Control Trial

  2022cites this paper
• Association of insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus

  2022cites this paper
• The Role of Growth Hormone in Chronic Kidney Disease.

  2021cites this paper
• Growth Hormone and Insulin-Like Growth Factor Dysregulation in Pediatric Chronic Kidney Disease

  2021cites this paper
• Association between serum insulin like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 levels and chronic kidney disease in diabetic patients

  2020cites this paper
• Chronic Kidney Disease and Dietary Measures to Improve Outcomes.

  2019cites this paper
• Endocrine disorders in chronic kidney disease

  2019cites this paper
• Evaluation of serum insulin-like growth factor-1 and 26S proteasome concentrations in healthy dogs and dogs with chronic diseases depending on body condition score.

  2018cites this paper
• Biomarkers of GH action in children and adults.

  2018cites this paper
• Homocysteine, insulin‐like growth factor one and oestrogen levels in patients with erectile dysfunction‐associated chronic hepatitis C virus infection

  2018cites this paper
• Growth and Nutrition in Pediatric Chronic Kidney Disease

  2018cites this paper
• Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

  2017cites this paper
• Free dissociable IGF-I: Association with changes in IGFBP-3 proteolysis and insulin sensitivity after surgery.

  2016cites this paper
• Low Insulin-Like Growth Factor-1 Level in Obesity Nephropathy: A New Risk Factor?

  2016cites this paper
• Effects of administration of subtoxic doses of acetaminophen on liver and blood levels of insulin-like growth factor-1 in rats

  2016cites this paper
• Endocrine and Growth Abnormalities in Chronic Kidney Disease

  2016cites this paper
• Chapter 22 – Somatic Growth and Maturation∗

  2016cites this paper
• IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.

  2015cites this paper
• Endocrine and Growth Abnormalities in Children with Chronic Renal Disease

  2015cites this paper
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

  2015cites this paper
• Growth Hormone Levels in ESRD Patients

  2014cites this paper
• Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.

  2014cites this paper
• Impaired postprandial response of the insulin‐like growth factor system in maintenance haemodialysis

  2014cites this paper
• Determination of IGFs and their binding proteins.

  2013cites this paper
• Serum IGF-1 levels correlate negatively to liver damage in diabetic rats

  2013cites this paper
• Interactions of the IGF System with Diabetes and its Vascular Complications.

  2013cites this paper
• Association between the ratio of insulin-like growth factor-I to insulin-like growth factor binding protein-3 and inflammation in incident automated peritoneal dialysis patients.

  2013cites this paper
• Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study

  2013cites this paper
• Interstitial fluid contains higher in vitro IGF bioactivity than serum: a study utilizing the suction blister technique.

  2012cites this paper
• Insulin-like growth factors in normal and diseased kidney.

  2012cites this paper
• Association between serum insulin-like growth factor I or IGF-binding protein 3 and estimated glomerular filtration rate: results of a population-based sample

  2012influential citation
• IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes

  2012cites this paper
• Functional and total IGFBP3 for the assessment of disorders of the GH/IGF1 axis in children with chronic kidney disease, GH deficiency, or short stature after SGA status at birth.

  2012cites this paper
• Quantification of the GH/IGF-axis components: lessons from human studies.

  2012cites this paper
• Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1.

  2012cites this paper
• Measurement of free GH and bioactive IGF-I in non-diabetic haemodialysis patients treated with GH for 7 days.

  2012cites this paper
• IGFBP 2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes

  2012cites this paper
• Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

  2012cites this paper
• IGF-1 and atherothrombosis: relevance to pathophysiology and therapy.

  2011cites this paper
• Role of Growth Hormone Deficiency and Treatment in Chronic Kidney Disease

  2011cites this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.

  2011cites this paper
• Lack of circulating bioactive and immunoreactive IGF-I changes despite improved fitness in chronic kidney disease patients following 48 weeks of physical training.

  2011cites this paper
• Insulin‐like growth factor‐I and the liver

  2011cites this paper
• AACE Acromegaly Task Force Chair

  2011cites this paper
• Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis.

  2010cites this paper
• Association between IGF-1 and chronic kidney disease among US adults

  2010cites this paper
• IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.

  2010cites this paper
• Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy.

  2010cites this paper
• Bioactive rather than total IGF-I is involved in acute responses to nutritional interventions in CAPD patients.

  2010cites this paper
• KAPITEL 72 – Hormonveränderungen bei Niereninsuffizienz und Leberzirrhose

  2010cites this paper
• Ascites from patients with alcoholic liver cirrhosis contains higher IGF‐I bioactivity than serum

  2010cites this paper
• IGF-I Bioactivity in Aging, Health and Disease

  2010cites this paper
• Insulin-glucose infusion given before hemodialysis increases IGF-I in type 2 diabetes patients with chronic kidney disease.

  2010cites this paper
• Figitumumab (CP-751,871) for cancer therapy

  2010cites this paper
• Endocrine and Growth Disorders in Chronic Kidney Disease

  2009cites this paper
• Lack of effect of IGF-I on the glomerular filtration rate in non-diabetic patients with advanced chronic kidney disease.

  2009cites this paper
• Endocrine and Neurologic Manifestations of Chronic Kidney Disease

  2009cites this paper
• Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise

  2008cites this paper
• Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.

  2007cites this paper
• Value of insulin-like growth factor system markers in the assessment of growth hormone status.

  2007cites this paper
• Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients

  2007cites this paper
• Growth and body composition in children with chronic kidney disease

  2007cites this paper
• Inhibition of the renin-angiotensin system in normotensive type 2 diabetes: effects and mechanisms of action

  2007cites this paper
• Utility of Free IGF-I Measurements

  2007cites this paper
• Insuficiencia renal crónica y déficit de crecimiento

  2006cites this paper
• Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition.

  2006cites this paper
• The IGF‐I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial

  2006cites this paper
• Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.

  2006cites this paper
• Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects.

  2006cites this paper
• Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?

  2006cites this paper
• Serum growth hormone and insulin-like growth factor-1 concentrations in Japanese black cattle with renal tubular dysplasia.

  2005cites this paper
• The Growth Hormone Hypothesis - 2005 Revision

  2005cites this paper
• Growth hormone/insulin-like growth factor system in children with chronic renal failure

  2005cites this paper
• Acromegaly: Diagnostic Pitfalls

  2004cites this paper
• The Kidney and the Insulin-Like Growth Factor System in Health and Disease

  2004cites this paper
• IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients.

  2004influential citation
• IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients

  2004influential citation
• Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice.

  2004cites this paper
• Influence of Energy Deficiency on the Insulin-like Growth Factor I Axis in a Military Training Program

  2004cites this paper
• Heart-kidney interactions in ischemic syndromes.

  2004cites this paper
• Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis.

  2004influential citation
• Growth hormone, IGF‐I and its binding proteins (IGFBP‐1 and ‐3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis

  2004cites this paper
• Pitfalls in the Biochemical Assessment of Acromegaly

  2004cites this paper
• The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients

  2003cites this paper
• A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.

  2003cites this paper
• Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

  2003cites this paper
• Malnutrition in peritoneal dialysis patients: causes and diagnosis.

  2003cites this paper
• Circulating free insulin-like growth-factor-I (IGF-I) levels should also be measured to estimate the IGF-I bioactivity

  2003cites this paper
• Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth.

  2003cites this paper
• Inhibin B Predicts Oocyte Number and the Ratio IGF-I/IGFBP-1 May Indicate Oocyte Quality During Ovarian Hyperstimulation for In Vitro Fertilization

  2003cites this paper
• Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.

  2003cites this paper
• Current concepts in the biochemical assessment of the patient with acromegaly.

  2003cites this paper
• The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications

  2002cites this paper
• Physical capacity influences the response of insulin-like growth factor and its binding proteins to training.

  2002cites this paper